0001493152-20-013713.txt : 20200721 0001493152-20-013713.hdr.sgml : 20200721 20200721170647 ACCESSION NUMBER: 0001493152-20-013713 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20200718 FILED AS OF DATE: 20200721 DATE AS OF CHANGE: 20200721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buell Jennifer CENTRAL INDEX KEY: 0001711184 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51353 FILM NUMBER: 201039471 BUSINESS ADDRESS: BUSINESS PHONE: 781-674-4400 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagenic Therapeutics, Inc.\new CENTRAL INDEX KEY: 0001022899 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 061390025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: (212) 994-8200 MAIL ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: Atrinsic, Inc. DATE OF NAME CHANGE: 20090630 FORMER COMPANY: FORMER CONFORMED NAME: NEW MOTION, INC. DATE OF NAME CHANGE: 20070504 FORMER COMPANY: FORMER CONFORMED NAME: MPLC, Inc. DATE OF NAME CHANGE: 20050608 4 1 ownership.xml X0306 4 2020-07-18 0 0001022899 Protagenic Therapeutics, Inc.\new PTIX 0001711184 Buell Jennifer 149 FIFTH AVE, SUITE 500 NEW YORK NY 10010 1 0 0 0 PTIX Common stock Options 1.75 2020-07-18 4 A 0 145000 1.75 A 2020-07-18 2030-07-18 PTIX Common Stock, Par Value $0.0001 145000 145000 D 100,000 of the options vest monthly over 48 months, commencing on the date of grant, while the other 45,000 options vest monthly over 12 months. Exhibit 24.2-Power of Attorney /s/ Jennifer Buell 2020-07-21 EX-24.2 2 ex24-2.htm

Exhibit 24.2

July 20, 2020

POWER OF ATTORNEY

KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Alexander K. Arrow, MD as the undersigned’s true and lawful attorney-in-fact to: (i) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or of Protagenic Therapeutics, Inc., a Delaware corporation (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (ii) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 and 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (iii) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in- fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of date first written above.

	Jennifer Buell

GRAPHIC 3 ex24-2_001.jpg begin 644 ex24-2_001.jpg M_]C_X 02D9)1@ ! 0$ 9 !D #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BD'2C:, M8H 6BBB@ HHHH ***, T %%%% !128HP* %HHQ10 4444 )10>E':@!:*** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $%+35( ZTN1Z MT+74!:*** "BBB@ HI-PSBC<* %HIOF+Z_I2[A_D4 +12%@!DTF]3WH =12; MA_D4F]<9S0 ZBDW"D\Q<@9/Y4 .IHH+C''6O-_B+\2%\/[= T(&\\37F(X84 M&[R"W1F[9]!^)XZ@%KQ!\2H['QKIOA71K(:GJ,\RKN3_ '@,DCL! M[UZ!7!?#CX>Q>"]-DNKV3[9KUZ=]Y=M\Q!/)12>2,\D]6//H!WM !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 45!/<0VEO)<7$J10QJ6>1VPJ@=22>E>.>(O'FJ^.Y+ MW2/!T@L-#ME)U+7YR41$ ^8(>W'XGV') )?B?\9K?04GT7PW/'<:IRDUTN&2 MV/0@=F?] >OI3O@W\/[BP1O%_B!9)-9O\O")^6B1N2[9_C;\P/J17*_#'X?: M=XG\0_VTMFP\-Z:_EVGGI\]](/XW]L\X' X7LV?HV@ HHHH ***YK4_'GA?1 MM6BTN_UFWBOI7"+",N0QZ!MH.W_@6* .EHHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L+Q-XKTCPEI3 M:CK%VL,0X1 ,O*W]U5ZD_P NIP*P/''Q)LO"LB:98PMJGB"X^6"P@^8J3T+X MY ]NI]AR,7PU\-K[6=5B\4_$*;[=J9^:'3S@P6HZ@$#@D>G3UW'F@#*@TOQ- M\8KA+S6O.T?P@CAX+!@_BJ#7(XO&.N0?#3P@B67AW3COU:XM MQ\HP?N ]SG/7.6Y/W374?$SQC>:=]F\)^&_WOB/5?W<80\VT9ZN?0X!QZ $] MN>@\">#K7P3X@ JY110 445X[\;OB*= T[_ (1S2YF34KR/,\J'F"(]O9FY'L,GTH J M^/\ XG75]Q31Z)!+YMO]I;]]=NIR';L%SR?ICGDFY\-/AI=>)+2SU#7[9K3P];-YEK MIQR#=R8YEDZ9!]3U' PO7Z"AAC@B2*)%2-%"JB# 4#H .PH FHHHH **** " MBBB@ HHHH **** "BJ5]JFGZ5 9]1O;:TB R7N)50?F37#:Q\;/!6E,8H+Z; M4[C('E6,1?)/HQPI_ T >C45Y'_PL+Q]XA8IX8\"2VT18!;K57*#'&3M.W]" MW]*4^ /B%XC8/XF\<-9PEB3::2I08]-PV_J&H ];HJCI-@NDZ1::>MQ-<"WB M6,37$FZ1\#JQ[FB@"]1110 4444 %%%% !1110 445RWC'QYH?@FP,^IW(,[ M F&TB(,LOT'8>YXH Z.66."%Y9I$CC0%F=VP%'J2>E>3:W\1M6\6:A+X=^'$ M!N)>5N-7<;88!TRI(_7_ +Y!ZU5@\.^,/BO,EWXI>70O#6Y7BTJ'_63@<@L3 MSZ[>RB@#<^&?@V]L&NO%GB3][XCU;YWW#FWC.,(/0\#/H !V.? M2J** "BBB@#*\0:U;>'= O=7N\F"TA:0J#RQ'11GN3@#ZUXK\-/ :&\-S.TL5FKAQN#8S(.P&,!3V'/I72?%V:7Q!KGAGP';28&IW(N+S:V&$ M*>WX.?J@JW?? WPP]U]KT:YU/1+C!^:RN3CG_>R?P!% 'IX P!2UY*OA# MXH^'!2?W&JQG<1Z;CN)_P"^A21_%;7O#,J0>/O"L]A$Q"_;[+]Y M#GW&3^C$^U 'K=%9VD:QIVNZ;%?Z7>1W5K)]V2,Y'N#W!]CS6C0 453OM3L= M+@,^H7EO:0J,F2>544?B37#ZQ\;/ ^D[E74WOI5&=EE$9,_1CA?UH ]$HKR5 MOB9XRUS>OA;X?WI4K\ESJ3>4A)]CM!_!Z)/"_P 5_$>[^UO%MGHMNXQY.F1% MF'KS\I'_ 'V: /3K[4['2X#/J%Y;VD*C)DGE5%'XDUQ&K_&KP1I3-''J+ZA. M.D=C$9-Q] QPOZU1M/@5X9-P;G6[O4]:N& #/=W) _\ '<-^;&NXTCPIH&@G M.DZ-8V;8P7B@4.?JV,G\Z //V^(_CC7@R^%O -TD9X6YU1O+7Z[3M!_!C33X M2^*GB'=_;7C&VT>!_P#EAID9+ =_F&TC_OHUZW10!YA8? WPM'?4=:N MB03)>W)PX!'YB@"W1110 56O+VUTZTDN[RXBM[>)=TDLKA54>I)KA/%7Q;T?0KDZ7 MI<4NMZTQ*I9V0+@-SPS 'TZ#)]A6':_#[Q+X\NDU/XAWS0V@;=#HMF^U$'^V M1W_$GW'2@!VH_$O6_%U]+HWPXT]YRI*S:OM;/A+X5V6B M7HUK7;E]=U]SN:[N(=(\.VGVK6-0M[*'L9GP6/7"CJQ]@#7CGBGXK7?CAW\)^ [ M*ZEGO,QR7;XC/E_Q;0?N@CJS8P.V30!:U[4&^+/BYM$M;KR?!VCOYFI78;:E MS(#]T-Z=0#TZM_=K9U?XT>#/"\4.F:.K:B8 L4<-@H$2*!P QX/&/NYKS/Q! M\.[GP;X0M8M=U26\O;N;RK#1K%R(FE)^^YQER,CH >B[L8(]*^&?P>L/"T4. MJZPD=WK6,J#S';9[*.[?[7Y>I /2=*OFU/2K.^:VFM3<0I*8)AAX]PSM8=B* MO444 %%%'+=/1J]1T;0_BY>Z-8Z8U]IOAJPM85@58U$DVQ5 MVCNW.!G[PH ]@N[RVL8#/=W$-O$O5YG"*/Q-@KO'\*?%;Q#N_M;QA9Z/"XQY.FQ%F7\?E/_CQKNO" M'A;3_!OA^#2-/7Y5^:21AAII".7;W./P [5T% 'EUI\"O#)N#&V+! M/,5<'.(P&Q@\D\&MSQ'?VECHTHO=4M--2?\ <+<74RQ*"P.<%N"V Q ]JQ-0 M\7>'?LEO#I7C#P];/!(A DOHRAC7@H0''4<>W7G&* +OAS68;^RN+Z'78=6T MR.)2ET @D! 8N) @ !QM/W5^E:6A1.FDI/,I6>Z9KB16Z@N,HC$NQ8A=SLK8^Z,>IK'\0VMMXLUJZ_M7 MXMZ5!H+N1'865W%&3&1@*QWX/N3NSSP.@8O(['Q1\6/#/AF8VBW+:CJ1(1;* MQ'F,6)P 3T!]LY]JY;^S/B)\3&_XFS-X5\//UM8R?M,RX'#=#Z]=H_V36]X9 MC^%?A%0=)U?P\EQC!N9-0A>8^OSEL@>PP/:NBE\>^#XXV<^*M%(4$D+?Q,?P M ;)^@I##PKX&T#P=:^3I%BL,:W^T#I*7 L_#E@U M_,QVK<7G^)_B3X6\)!DU/4D-T/^76#]Y+^('W?^!8KC6\3_$?QV=GAC1U\/Z6_34= M0_UC+QRJD'J,]%/^\*N>%](^$GA01RV6LZ!/>)TNKO489),^HR<+_P ! KH= M=^)OA+1M&N;]=-,I;6MW'))(W8 *2>O?H* /+_%OA/0_!%DM_KMW<^* M_%M\WEV4-T69"^<;O+!)906Z$G)P !S7H7PP\!GP?I,EYJ.V37=0_>7<@ _= MCJ(UQQ@=\<9]@*XWX>W>B:CKA8#*_R]3UKS2^^.]WK%V;/PKIUE;#@?;-9O(X5 SUVE@.G/WB?;U@&BV?BC M$OCKXL:;<1L038:?J,,<0YSCK@]OX<^] 'H6O_%KP9X=WI/JT=W<+N'D60\U MLCJ"1\H/U(KG?^%@>//%)V>$_!KV=NW OM5.T8]0O'Z%JU?#\?PG\,E6TO4/ M#4,R])WOXI)?^^V8D?@:Z;_A._"'_0UZ'_X,8?\ XJ@#@O\ A5GBCQ*N[QKX MWO)8G&&LM.Q''SVS@*?^^*Z;1OA/X*T(*T&A07$H(_>W>9SD=\-D#\ *U_\ MA._"'_0UZ'_X,8?_ (JL+Q#\8/!GA^'=_:T6HS$96'3W$Q/U8':/Q- 'EW@C MP'KD_P 39+34K*>'1M'U&>^4R1%8Y9"0$VGH<[$;C. #ZU[!XN^(GA_P;&4U M"[\V^892Q@^:9\]./X1[G%>62?$/Q%X_E:*U\0:+X/T=N&EFU&+[4PYZ#<&! MZ= OU-=3X3T;X7>%)1>)XDT:_P!5)+O?W>HPO)N./\ A4A_\ @QA_^*H_X3OPA_T->A_^#&'_ .*H Z"BN?\ M^$[$?\ 0UZ'_P"#&'_XJC_A._"'_0UZ'_X,8?\ XJ@#H**Y_P#X3OPA_P!# M7H?_ (,8?_BJ/^$[\(?]#7H?_@QA_P#BJ .@HK(T[Q+H6KSM;Z7K6G7TZJ7: M.UNDE8+D#)"DG&2!GW%:] !1110 4444 %%%% !1110 4444 %%%% !1110 M4QE5U*L RD8((R"*?10!!;VT%I"(;>".&(=$C0*H_ 5/14,TL=O$\LKJD:*6 M9V. H'))/84 5-7U:QT+2KG4]0F6&UMT+R.W8>@'@!(')^\0 ,A>9_'>H^(/BO%JC^&[>:3PYHQ&U M4!+7LV1D@=\*20.> .[ "GX&\6^!/ D:RZMHFM-XA"!IY[BV0E6_NQAG!4=> M2 3CD]J .XS\4/B%RA3P?H[]"03=.OZ,/_'/QKH/#OPA\+:!+]JGMY-7OR=S M76H'S3N]0O0?7!/O60GQRL+R,-IGA3Q'=[AE-MJN&_%6;O3$^(WC[4PXTKX: MW<7)"/?3F/([$AE3U'?UYH ]850JA5 "@8 '04$A022 !R2:\G%I\:=:6,SZ MAHFA1GEUA02.!ZM_KUIYJ'!A@;SI ?0JF7J^ M7""#CL<'\6!KKM$^&'@W0&5[+0;9I@6_X33Q7]DL7SG3M*&T$$=&; 'KUW_6NT\-?#[PQX257TK2HUN M,?:9?WDI_P"!'I^&!7544 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !7C?C'6;_ .(WB5O ?AJ=H]-@8'6+ M^/E0H/,8/].Y&.@-:/Q'\8W\U]'X&$,9=?OQMN)D;BSB(Y)8?=..<]0.>I% M==X+\'6'@GP]%IEDH9^&N)R/FFDQRQ]NP'84 :6B:+8>'=(M]+TR!8;2W7:B MCJ?4D]R3R36G110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %<1\2O&%UX3T.!=,M9+ MC5M1F^RV2@9"N1]X^N.P[GVS7;TAH X7X<^!/^$3L9KS4I3=>(-0;S;ZZ)S@ MGG8I] >I[GVP!W=%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ? %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$! end